×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

TETRAGON PARTNERS GP LTD

AUM: $19.69 B
13-F Portfolio Value: $515.11 M
Last 13-F Filed: Q1 2026
Concentration in top 10: 82.01%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
FOLDAMICUS THERAPEUTICS INC-260,771Exited13F
ZVRAZEVRA THERAPEUTICS INC-192,518Exited13F
RAPTRAPT THERAPEUTICS INC-131,770Exited13F
AVDLAVADEL PHARMACEUTICALS PLC-43,763Exited13F